Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer

• Juan R. Cubillos-Ruiz ^[2] ; Sarah E. Bettigole ^[3] ; Laurie H. Glimcher ^[1]
  1. [1] Dana–Farber Cancer Institute

     Dana–Farber Cancer Institute

     City of Boston, Estados Unidos

     
  2. [2] Weill Cornell Medicine
  3. [3] Quentis Therapeutic

  Mostrar afiliaciones +
• Localización: Cell, ISSN 0092-8674, Vol. 168, Nº. 4, 2017 (Ejemplar dedicado a: Cancer, the road ahead), págs. 692-706
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Malignant cells utilize diverse strategies that enable them to thrive under adverse conditions while simultaneously inhibiting the development of anti-tumor immune responses. Hostile microenvironmental conditions within tumor masses, such as nutrient deprivation, oxygen limitation, high metabolic demand, and oxidative stress, disturb the protein-folding capacity of the endoplasmic reticulum (ER), thereby provoking a cellular state of “ER stress.” Sustained activation of ER stress sensors endows malignant cells with greater tumorigenic, metastatic, and drug-resistant capacity. Additionally, recent studies have uncovered that ER stress responses further impede the development of protective anti-cancer immunity by manipulating the function of myeloid cells in the tumor microenvironment. Here, we discuss the tumorigenic and immunoregulatory effects of ER stress in cancer, and we explore the concept of targeting ER stress responses to enhance the efficacy of standard chemotherapies and evolving cancer immunotherapies in the clinic.